[Differential therapy of Crohn disease].
Strohm
W D
WD
Classen
M
M
D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000473:pathology / Q000628:therapy*; D005526:Food, Formulated; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000473:pathology; D008795:Metronidazole / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D012459:Salicylates; D008795:Metronidazole; D012460:Sulfasalazine; D011239:Prednisolone
Die Differentialtherapie der Crohnschen Erkrankung.